Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xuan Qiu

Showing results (191-200 of 205) with videos related to

Pageof 21
Sort By:
International Journal of Oncology|August 2, 2011
Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activationWei-Tian Wei, Hui Chen, Zhong-Lin Ni, et al.
Frontiers in Pharmacology|March 8, 2024
Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillationYang-Qi Pan, Lu-Shen Jin, Sang Qian, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2020
Development and characterization of a novel anti-OX40 antibody for potent immune activationZhihui Kuang, Hua Jing, Zhihai Wu, et al.
Drug Design, Development and Therapy|January 30, 2015
Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cellsFeng Wang, Hai Li, Xiao-Gang Yan, et al.
Drug Design, Development and Therapy|January 30, 2015
Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cellsFeng Wang, Qi Wang, Zhi-Wei Zhou, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2020
Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicityYan Wang, Haiqing Ni, Shuaixiang Zhou, et al.
Frontiers in Surgery|April 27, 2026
Feasibility of embryonic-natural orifice transluminal endoscopic surgery for submucosal tumors with mucosal preservation in beagle modelHan Lin, Chuan-Shen Jiang, Dong-Gui Hong, et al.
Drug Design, Development and Therapy|January 28, 2015
Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cellsYong-Hui Ding, Zhi-Wei Zhou, Chun-Fang Ha, et al.
Drug Design, Development and Therapy|March 4, 2015
The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cellsJin-Ping Li, Yin-Xue Yang, Qi-Lun Liu, et al.
Journal of Translational Medicine|October 16, 2023
Personalized radiomics signature to screen for KIT-11 mutation genotypes among patients with gastrointestinal stromal tumors: a retrospective multicenter studyQing-Wei Zhang, Ran-Ying Zhang, Zhi-Bo Yan, et al.
Pageof 21

Showing results (191-200 of 205) with videos related to

Sort By:
Pageof 21
International Journal of Oncology|August 2, 2011
Antitumor and apoptosis-promoting properties of emodin, an anthraquinone derivative from Rheum officinale Baill, against pancreatic cancer in mice via inhibition of Akt activationWei-Tian Wei, Hui Chen, Zhong-Lin Ni, et al.
Frontiers in Pharmacology|March 8, 2024
Twice-daily rivaroxaban after percutaneous left atrial appendage closure for atrial fibrillationYang-Qi Pan, Lu-Shen Jin, Sang Qian, et al.
Cancer Immunology, Immunotherapy : CII|February 21, 2020
Development and characterization of a novel anti-OX40 antibody for potent immune activationZhihui Kuang, Hua Jing, Zhihai Wu, et al.
Drug Design, Development and Therapy|January 30, 2015
Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cellsFeng Wang, Hai Li, Xiao-Gang Yan, et al.
Drug Design, Development and Therapy|January 30, 2015
Plumbagin induces cell cycle arrest and autophagy and suppresses epithelial to mesenchymal transition involving PI3K/Akt/mTOR-mediated pathway in human pancreatic cancer cellsFeng Wang, Qi Wang, Zhi-Wei Zhou, et al.
Cancer Immunology, Immunotherapy : CII|August 8, 2020
Tumor-selective blockade of CD47 signaling with a CD47/PD-L1 bispecific antibody for enhanced anti-tumor activity and limited toxicityYan Wang, Haiqing Ni, Shuaixiang Zhou, et al.
Frontiers in Surgery|April 27, 2026
Feasibility of embryonic-natural orifice transluminal endoscopic surgery for submucosal tumors with mucosal preservation in beagle modelHan Lin, Chuan-Shen Jiang, Dong-Gui Hong, et al.
Drug Design, Development and Therapy|January 28, 2015
Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cellsYong-Hui Ding, Zhi-Wei Zhou, Chun-Fang Ha, et al.
Drug Design, Development and Therapy|March 4, 2015
The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cellsJin-Ping Li, Yin-Xue Yang, Qi-Lun Liu, et al.
Journal of Translational Medicine|October 16, 2023
Personalized radiomics signature to screen for KIT-11 mutation genotypes among patients with gastrointestinal stromal tumors: a retrospective multicenter studyQing-Wei Zhang, Ran-Ying Zhang, Zhi-Bo Yan, et al.
Pageof 21